icd10free.comPowered by Curo

ICD-10 Coding for Bicytopenia(D61.1, D61.81, D61.818)

Save

Learn about the ICD-10 coding for bicytopenia, including documentation requirements and common pitfalls. Ensure accurate billing and compliance.

Also known as:
Dual cytopeniaTwo-line cytopenia
Related ICD-10 Code Ranges

Complete code families applicable to Bicytopenia

D50-D89Primary Range

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
D61.1Drug-induced aplastic anemia with bicytopenia
D61.818Other pancytopenia
Primary ICD-10-CM Codes
Drug-induced aplastic anemia
D61.1Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Other pancytopeniaD61.818
Drug-induced aplastic anemia with bicytopeniaD61.1

Documentation & Coding Risks

Avoid these common issues when documenting Bicytopenia.

Failing to document drug cause for bicytopenia

Impact

Clinical: Leads to mismanagement of underlying cause., Regulatory: Increases risk of non-compliance with coding standards., Financial: Potential for reduced reimbursement.

Mitigation

Always document drug name and dosage., Link cytopenia onset to drug administration.

Using D64.9 for bicytopenia without specifying cause

Impact

Reimbursement: May lead to lower reimbursement rates., Compliance: Increases risk of audit due to unspecified coding., Data Quality: Reduces accuracy of clinical data.

Mitigation

Use specific codes like D61.1 or D61.818 based on etiology.

Unspecified cytopenia coding

Impact

Using unspecified codes increases audit risk.

Mitigation

Document specific cell lines and causes.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with D61.1.